This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Epidemiology

Authoring team

The incidence of motor neurone disease in the UK has been shown to approach 2 to 3 per 100,000 population, while a lower frequency (less than 1 per 100,000) of ALS has been demonstrated in the South and East Asian community. (1)

Onset is typically in the sixth and seventh decades and the male to female ratio is 2:1 (2)

About 5-10% of cases are inherited and approximately 10 to 15 percent of individuals with ALS have familial disease. (3)

Male sex, increasing age and hereditary disposition are the main risk factors. (4)

References

  1. Alonso A, Logroscino G, Jick SS, Hernán MA. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study. Eur J Neurol. 2009 Jun;16(6):745-51
  2. Orrell RW; GPs have key role in managing motor neurone disease. Practitioner. 2011 Sep;255(1743):19-22, 2.
  3. Boylan K. Familial Amyotrophic Lateral Sclerosis. Neurol Clin. 2015 Nov;33(4):807-30.
  4. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force; European Federation of Neurological Societies (2011)

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.